IL6 and periodontitis: Based on our above studies in network pharmacology and molecular docking, we screened and predicted that Kaempferol treatment exhibits a high binding affinity for IL6, CASP3, and MMP9, suggesting that these proteins may be the primary targets of Kaempferol in the treatment of periodontitis.